CarePoint Partners

About CarePoint Partners

Established in 2007 and headquartered in Cincinnati, Ohio, CarePoint Partners carved a significant niche in the North American healthcare landscape as a provider of home infusion and specialty pharmacy services. The company was strategically formed through a partnership between its CEO, Dana Soper, and the private equity firm Waud Capital Partners, with the objective of acquiring and developing a network of infusion pharmacies. Dana Soper, a pharmacist by training with a Bachelor's from West Virginia University and an MBA from Xavier University, brought extensive industry experience to her role as CEO.

CarePoint Partners' business model centered on an aggressive acquisition strategy, successfully integrating 16 different companies to build a robust network. This approach established it as one of the top five home infusion platforms in the United States. The company specialized in administering medications and nutrients to patients with complex, acute, and chronic illnesses in their homes or at alternate-site infusion centers, thereby avoiding costly hospital visits. Its services included intravenous, subcutaneous, and epidural methods for delivering therapies like antibiotics, IVIG, and nutrition, alongside related nursing services and specialty injections. By 2013, the company was serving approximately 20,500 patients annually through 28 service sites across nine states, generating around $160 million in revenue.

A pivotal moment in the company's history occurred in August 2013, when it was acquired by BioScrip, Inc. for $223 million. This transaction was a strategic move by BioScrip to significantly expand its national footprint in the highly fragmented home infusion market. Following the acquisition, Dana Soper transitioned to a role as SVP of Field Operations at BioScrip. The combined entity aimed to serve over 100,000 patients annually. The story continued when BioScrip merged with Option Care in 2019, creating a new market leader named Option Care Health, which is now the largest independent provider of home and alternate site infusion services in the U.S.